（文章来源：每日经济新闻） 东阿阿胶（SZ 000423，收盘价：51.13元）8月21日晚间发布半年度业绩报告称，2025年上半年营业收 入约30.51亿元，同比增加11.02%；归属于上市公司股东的净利润约8.18亿元，同比增加10.74%；基本 每股收益1.2698元，同比增加10.52%。 ...

格隆汇8月21日丨东阿阿胶(000423.SZ)公布2025年半年度报告，上半年公司实现营业收入30.51亿元，同 比增长11.02%；归属于上市公司股东的净利润8.18亿元，同比增长10.74%；归属于上市公司股东的扣除 非经常性损益的净利润7.88亿元，同比增长12.58%；基本每股收益1.2698元；拟向全体股东每10股派发 现金红利12.69元(含税)。 ...

Group 1 - The core viewpoint emphasizes that promoting digital transformation in manufacturing is essential for building a strong manufacturing city and achieving high-quality industrial economic development [1] - The city has established a "1+N+X" mechanism to support digital transformation, which includes creating a new industrial smart platform, planning multiple industry platforms, and cultivating various application scenarios [1][2] - The government has issued policies to support high-quality development in manufacturing, with a focus on digital transformation initiatives [1][4] Group 2 - The city is actively advancing the construction of digital transformation service platforms, focusing on key industrial chains and clusters, and has initiated five provincial-level "industry brain" pilot projects [2] - A digital transformation assessment system for small and medium-sized enterprises has been launched, with 1,312 companies evaluated this year [2] - The "Chat City Enterprise Home" intelligent service system has been developed to provide one-stop services, including policy interpretation and supply-demand matching, with nearly 400 solutions and service products available [2] Group 3 - The city encourages collaboration between service providers and manufacturing enterprises to explore digital technology applications and has identified five pilot projects for industry-wide transformation [3] - The city is leveraging opportunities in "artificial intelligence + manufacturing" and has successfully selected five projects for provincial-level industry model initiatives [3] - Several companies have been recognized for their digital transformation achievements, including Dong'e Ejiao Co., Ltd., which was named a "digital leader" by the Ministry of Industry and Information Technology [3] Group 4 - A comprehensive policy framework has been established to stimulate enterprise transformation, including action plans and funding support totaling nearly 280 million yuan since 2022 [4] - The policies cover various aspects such as technological upgrades, platform construction, and exemplary cases to ensure effective implementation [4] - Specific financial incentives have been introduced to support enterprises in areas like industrial internet platforms and smart factories, encouraging active participation in these initiatives [4]

Core Viewpoint - Dong'e Ejiao announced a revenue of 3.051 billion yuan for the first half of 2025, representing a year-on-year growth of 11.02% [1] - The net profit attributable to shareholders reached 818 million yuan, with a year-on-year increase of 10.74% [1] - The net profit after deducting non-recurring gains and losses was 788 million yuan, showing a year-on-year growth of 12.58% [1]

智通财经APP讯，华润医药(03320)发布公告，东阿阿胶公布其截至2025年6月30日止6个月的半年度报 告，该公司取得营业总收入人民币30.51亿元，同比增加11.02%;上市公司股东应占净利润8.18亿元，同 比增加10.74%;每股基本盈利1.27元。拟每10股分配现金股息人民币12.69元(含税)。 ...

东阿阿胶8月21日晚间公告，董事会同意，公司通过进场摘牌方式以自有资金预计3379.852万元收购东 丰城市发展投资（集团）有限公司（下称"城发集团"）持有的东丰马记药业有限公司（下称"马记药 业"）70%股权。收购完成后，公司将持有马记药业70%股权，城发集团将持有马记药业30%股权。本次 交易完成后，马记药业将成为公司控股子公司，纳入合并报表范围。本次交易目前处于挂牌转让阶段， 尚未签署合同，协议内容和具体操作方式以各方最终签署的正式协议为准。 ...

Group 1 - The company announced a donation of 4.3 million yuan to the China Women's Development Foundation, which includes a cash donation of 2.6 million yuan and in-kind donations valued at 1.7 million yuan [1] - The purpose of the donation is to support the Healthy China initiative and rural revitalization strategy, aiming to improve the medical environment for grassroots citizens and enhance the company's visibility and reputation [1] - The donation does not involve related party transactions and does not constitute a major asset restructuring, having no significant impact on the company's financial status and operating results [1]

东阿阿胶公告，2025年上半年营业收入30.51亿元，同比增长11.02%。净利润8.18亿元，同比增长 10.74%。拟向全体股东每10股派发现金红利12.69元（含税）。 ...

东阿阿胶股份有限公司（以下简称"公司"）于 2025 年 8 月 20 日召开第十 一届董事会第十一次会议，审议通过了《关于对外捐赠的议案》。现将有关情况 公告如下： 一、对外捐赠事项概述 为积极响应健康中国建设以及乡村振兴战略号召，支持华润健康乡村公益项 目，同时提升公司知名度与美誉度、彰显国企责任与担当，公司拟向中国妇女发 展基金会捐赠 430 万元，其中包括资金捐赠 260 万元以及实物捐赠价值 170 万元。 根据《深圳证券交易所股票上市规则》《公司章程》等相关规定，本议案经董事 会审议通过后即可实施，无需提交股东大会审议。 证券代码：000423 证券简称：东阿阿胶 公告编号：2025-49 东阿阿胶股份有限公司 关于对外捐赠的公告 本公司及董事会全体成员保证信息披露的内容真实、准确和完整，没有 虚假记载、误导性陈述或重大遗漏。 董 事 会 二〇二五年八月二十二日 1．第十一届董事会第十一次会议决议； 2．深交所要求的其他文件。 本次捐赠事项不涉及关联交易，也不构成《上市公司重大资产重组管理办法》 规定的重大资产重组。 二、对公司的影响 本次对外捐赠持续落实健康中国建设和乡村振兴战略，旨在进一步改善 ...

| 控股股东、实际控制人 | 华润科伦医药(四 | 同一控股股东 | 应收账款 | 4,256.39 | 4,256.39 | | 销售货物 | 经营性往 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 及其附属企业 | 川)有限公司 | | | | | | | 来 | | 控股股东、实际控制人 | 华润昆明医药有限 | 同一控股股东 | 应收账款 | 3.88 | 3.88 | | 销售货物 | 经营性 | | 及其附属企业 | 公司 | | | | | | | 往来 | | 控股股东、实际控制人 | 华润河北医药有限 | 同一控股股东 | 应收账款 | 288.99 | 288.99 | | 销售货物 | 经营性往 | | 及其附属企业 | 公司 | | | | | | | 来 | | 控股股东、实际控制人 | 华润医药商业(陕 | 同一控股股东 | 应收账款 | 65.01 | 65.01 | | 销售货物 | 经营性往 | | 及其附属企业 | 西)有限公司 | | | | | | | 来 | | 控股股东、实际控制人 | 华润医 ...